Varonis Announces Third Quarter 2024 Financial Results
| Varonis Systems, Inc. | |||||||||||||||
| Condensed Consolidated Statements of Operations | |||||||||||||||
| (in thousands, except for share and per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Unaudited | Unaudited | ||||||||||||||
| Revenues: | |||||||||||||||
| Term license subscriptions | $ | 68,751 | $ | 83,963 | $ | 187,460 | $ | 250,306 | |||||||
| SaaS | 57,805 | 13,716 | 136,575 | 21,437 | |||||||||||
| Maintenance and services | 21,512 | 24,629 | 68,401 | 73,318 | |||||||||||
| Total revenues | 148,068 | 122,308 | 392,436 | 345,061 | |||||||||||
| Cost of revenues | 24,007 | 17,381 | 67,792 | 52,404 | |||||||||||
| Gross profit | 124,061 | 104,927 | 324,644 | 292,657 | |||||||||||
| Operating expenses: | |||||||||||||||
| Research and development | 53,459 | 44,818 | 146,219 | 135,694 | |||||||||||
| Sales and marketing | 71,378 | 68,610 | 212,646 | 207,324 | |||||||||||
| General and administrative | 22,864 | 20,646 | 65,878 | 61,618 | |||||||||||
| Total operating expenses | 147,701 | 134,074 | 424,743 | 404,636 | |||||||||||
| Operating loss | (23,640 | ) | (29,147 | ) | (100,099 | ) | (111,979 | ) | |||||||
| Financial income, net | 10,245 | 8,634 | 27,039 | 24,872 | |||||||||||
| Loss before income taxes | (13,395 | ) | (20,513 | ) | (73,060 | ) | (87,107 | ) | |||||||
| Income taxes | (4,938 | ) | (2,504 | ) | (9,711 | ) | (12,911 | ) | |||||||
| Net loss | $ | (18,333 | ) | $ | (23,017 | ) | $ | (82,771 | ) | $ | (100,018 | ) | |||
| Net loss per share of common stock, basic and diluted | $ | (0.16 | ) | $ | (0.21 | ) | $ | (0.74 | ) | $ | (0.92 | ) | |||
| Weighted average number of shares used in computing net loss per share of common stock, basic and diluted | 112,268,210 | 109,429,722 | 111,382,582 | 109,187,063 | |||||||||||
| Stock-based compensation expense for the three and nine months ended September 30, 2024 and 2023 is included in the Condensed Consolidated Statements of Operations as follows (in thousands): | |||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||
| Unaudited | Unaudited | ||||||||||
| Cost of revenues | $ | 1,357 | $ | 1,416 | $ | 4,017 | $ | 5,946 | |||
| Research and development | 10,442 | 11,323 | 31,057 | 37,480 | |||||||
| Sales and marketing | 9,860 | 11,201 | 30,985 | 37,861 | |||||||
| General and administrative | 10,272 | 9,040 | 28,054 | 26,889 | |||||||
| $ | 31,931 | $ | 32,980 | $ | 94,113 | $ | 108,176 | ||||
| Payroll tax expense related to stock-based compensation for the three and nine months ended September 30, 2024 and 2023 is included in the Condensed Consolidated Statements of Operations as follows (in thousands): | |||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||
| Unaudited | Unaudited | ||||||||||
| Cost of revenues | $ | 15 | $ | 24 | $ | 631 | $ | 385 | |||
| Research and development | 187 | 75 | 566 | 232 | |||||||
| Sales and marketing | 150 | 122 | 3,050 | 1,820 | |||||||
| General and administrative | 49 | 18 | 1,165 | 486 | |||||||
| $ | 401 | $ | 239 | $ | 5,412 | $ | 2,923 | ||||
| Amortization of acquired intangibles and acquisition-related expenses for the three and nine months ended September 30, 2024 and 2023 is included in the Condensed Consolidated Statements of Operations as follows (in thousands): | |||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||
| Unaudited | Unaudited | ||||||||||
| Cost of revenues | $ | 381 | $ | 382 | $ | 1,143 | $ | 1,144 | |||
| Research and development | - | 412 | - | 1,235 | |||||||
| Sales and marketing | - | - | - | - | |||||||
| General and administrative | - | - | - | - | |||||||
| $ | 381 | $ | 794 | $ | 1,143 | $ | 2,379 | ||||
| Varonis Systems, Inc. | |||||||
| Condensed Consolidated Balance Sheets | |||||||
| (in thousands) | |||||||
| September 30, 2024 | December 31, 2023 | ||||||
| Unaudited | |||||||
| Assets | |||||||
| Current assets: | |||||||
| Cash and cash equivalents | $ | 282,218 | $ | 230,740 | |||
| Marketable securities | 562,568 | 253,175 | |||||
| Short-term deposits | 34,174 | 49,800 | |||||
| Trade receivables, net | 119,203 | 169,116 | |||||
| Prepaid expenses and other short-term assets | 76,206 | 64,326 | |||||
| Total current assets | 1,074,369 | 767,157 | |||||
| Long-term assets: | |||||||
| Long-term marketable securities | 332,329 | 211,063 | |||||
| Operating lease right-of-use assets | 45,390 | 51,838 | |||||
| Property and equipment, net | 28,908 | 33,964 | |||||
| Intangible assets, net | 119 | 1,263 | |||||
| Goodwill | 23,135 | 23,135 | |||||
| Other assets | 16,904 | 15,490 | |||||
| Total long-term assets | 446,785 | 336,753 | |||||
| Total assets | $ | 1,521,154 | $ | 1,103,910 | |||
| Liabilities and stockholders' equity | |||||||
| Current liabilities: | |||||||
| Trade payables | $ | 1,489 | $ | 672 | |||
| Accrued expenses and other short-term liabilities | 123,256 | 125,057 | |||||
| Convertible senior notes, net | 251,625 | - | |||||
| Deferred revenues | 217,605 | 181,049 | |||||
| Total current liabilities | 593,975 | 306,778 | |||||
| Long-term liabilities: | |||||||
| Convertible senior notes, net | 449,759 | 250,477 | |||||
| Operating lease liabilities | 43,654 | 51,313 | |||||
| Deferred revenues | 1,530 | 886 | |||||
| Other liabilities | 3,676 | 4,808 | |||||
| Total long-term liabilities | 498,619 | 307,484 | |||||
| Stockholders' equity: | |||||||
| Share capital | |||||||
| Common stock | 112 | 109 | |||||
| Accumulated other comprehensive loss | (4,381 | ) | (8,649 | ) | |||
| Additional paid-in capital | 1,159,990 | 1,142,578 | |||||
| Accumulated deficit | (727,161 | ) | (644,390 | ) | |||
| Total stockholders' equity | 428,560 | 489,648 | |||||
| Total liabilities and stockholders' equity | $ | 1,521,154 | $ | 1,103,910 | |||
| Varonis Systems, Inc. | |||||||
| Condensed Consolidated Statements of Cash Flows | |||||||
| (in thousands) | |||||||
| Nine Months Ended September 30, | |||||||
| 2024 | 2023 | ||||||
| Unaudited | |||||||
| Cash flows from operating activities: | |||||||
| Net loss | $ | (82,771 | ) | $ | (100,018 | ) | |
| Adjustments to reconcile net loss to net cash provided by operating activities: | |||||||
| Depreciation and amortization | 8,543 | 8,736 | |||||
| Stock-based compensation | 94,113 | 108,176 | |||||
| Amortization of deferred commissions | 19,906 | 17,547 | |||||
| Non-cash operating lease costs | 7,050 | 7,087 | |||||
| Amortization of debt issuance costs | 1,264 | 1,133 | |||||
| Amortization of premium and accretion of discount on marketable securities | (11,288 | ) | (5,557 | ) | |||
| Acquired in-process research and development | 6,653 | - | |||||
| Changes in assets and liabilities: | |||||||
| Trade receivables | 49,913 | 24,895 | |||||
| Prepaid expenses and other short-term assets | (10,889 | ) | (11,118 | ) | |||
| Deferred commissions | (23,846 | ) | (18,338 | ) | |||
| Other long-term assets | (129 | ) | (963 | ) | |||
| Trade payables | 817 | (1,634 | ) | ||||
| Accrued expenses and other short-term liabilities | (5,882 | ) | (17,652 | ) | |||
| Deferred revenues | 37,200 | 33,555 | |||||
| Other long-term liabilities | 272 | 3,120 | |||||
| Net cash provided by operating activities | 90,926 | 48,969 | |||||
| Cash flows from investing activities: | |||||||
| Proceeds from maturities of marketable securities | 157,100 | 28,850 | |||||
| Investment in marketable securities | (576,753 | ) | (331,651 | ) | |||
| Proceeds from short-term and long-term deposits | 25,038 | 170,925 | |||||
| Investment in short-term and long-term deposits | (9,233 | ) | (118,605 | ) | |||
| Purchase of in-process research and development | (6,653 | ) | - | ||||
| Purchases of property and equipment | (2,342 | ) | (2,945 | ) | |||
| Net cash used in investing activities | (412,843 | ) | (253,426 | ) | |||
| Cash flows from financing activities: | |||||||
| Proceeds from issuance of convertible senior notes, net of issuance costs | 450,099 | - | |||||
| Purchases of capped calls | (55,522 | ) | - | ||||
| Proceeds from employee stock plans | 16,082 | 11,346 | |||||
| Taxes paid related to net share settlement of equity awards | (37,264 | ) | (19,971 | ) | |||
| Repurchase of common stock | - | (43,522 | ) | ||||
| Net cash provided by (used in) financing activities | 373,395 | (52,147 | ) | ||||
| Increase (decrease) in cash and cash equivalents | 51,478 | (256,604 | ) | ||||
| Cash and cash equivalents at beginning of period | 230,740 | 367,800 | |||||
| Cash and cash equivalents at end of period | $ | 282,218 | $ | 111,196 | |||
| Varonis Systems, Inc. | |||||||||||||||
| Reconciliation of GAAP Measures to non-GAAP | |||||||||||||||
| (in thousands, except share and per share data) | |||||||||||||||
| Three Months Ended September 30, | Nine Months Ended September 30, | ||||||||||||||
| 2024 | 2023 | 2024 | 2023 | ||||||||||||
| Unaudited | Unaudited | ||||||||||||||
| Reconciliation to non-GAAP operating income: | |||||||||||||||
| GAAP operating loss | $ | (23,640 | ) | $ | (29,147 | ) | $ | (100,099 | ) | $ | (111,979 | ) | |||
| Add back: | |||||||||||||||
| Stock-based compensation expense | 31,931 | 32,980 | 94,113 | 108,176 | |||||||||||
| Payroll tax expenses related to stock-based compensation | 401 | 239 | 5,412 | 2,923 | |||||||||||
| Amortization of acquired intangible assets and acquisition-related expenses | 381 | 794 | 1,143 | 2,379 | |||||||||||
| Non-GAAP operating income | $ | 9,073 | $ | 4,866 | $ | 569 | $ | 1,499 | |||||||
| Reconciliation to non-GAAP net income: | |||||||||||||||
| GAAP net loss | $ | (18,333 | ) | $ | (23,017 | ) | $ | (82,771 | ) | $ | (100,018 | ) | |||
| Add back: | |||||||||||||||
| Stock-based compensation expense | 31,931 | 32,980 | 94,113 | 108,176 | |||||||||||
| Payroll tax expenses related to stock-based compensation | 401 | 239 | 5,412 | 2,923 | |||||||||||
| Amortization of acquired intangible assets and acquisition-related expenses | 381 | 794 | 1,143 | 2,379 | |||||||||||
| Foreign exchange rate differences, net | (1,052 | ) | (1,002 | ) | (2,302 | ) | (3,206 | ) | |||||||
| Amortization of debt issuance costs | 496 | 379 | 1,264 | 1,133 | |||||||||||
| Non-GAAP net income | $ | 13,824 | $ | 10,373 | $ | 16,859 | $ | 11,387 | |||||||
| GAAP weighted average number of shares used in computing net loss per share of common stock - basic and diluted | 112,268,210 | 109,429,722 | 111,382,582 | 109,187,063 | |||||||||||
| Non-GAAP weighted average number of shares used in computing net income per share of common stock - basic | 112,268,210 | 109,429,722 | 111,382,582 | 109,187,063 | |||||||||||
| Non-GAAP weighted average number of shares used in computing net income per share of common stock - diluted | 134,713,048 | 126,748,606 | 134,821,002 | 126,777,843 | |||||||||||
| GAAP net loss per share of common stock - basic and diluted | $ | (0.16 | ) | $ | (0.21 | ) | $ | (0.74 | ) | $ | (0.92 | ) | |||
| Non-GAAP net income per share of common stock - basic | $ | 0.12 | $ | 0.09 | $ | 0.15 | $ | 0.10 | |||||||
| Non-GAAP net income per share of common stock - diluted | $ | 0.10 | $ | 0.08 | $ | 0.13 | $ | 0.09 | |||||||
| Varonis Systems, Inc. | |||||||
| Reconciliation of GAAP Measures to non-GAAP | |||||||
| (in millions) | |||||||
| Nine Months Ended September 30, | |||||||
| 2024 | 2023 | ||||||
| Unaudited | |||||||
| Reconciliation to non-GAAP free cash flow: | |||||||
| Net cash provided by operating activities | $ | 90.9 | $ | 49.0 | |||
| Purchases of property and equipment | (2.3 | ) | (3.0 | ) | |||
| Free cash flow | $ | 88.6 | $ | 46.0 | |||
| Varonis Systems, Inc. | |||||||
| Reconciliation of GAAP Measures to non-GAAP | |||||||
| (in millions) | |||||||
| Twelve Months Ended December 31, 2024 | |||||||
| Low | High | ||||||
| Reconciliation to non-GAAP free cash flow: | |||||||
| Net cash provided by operating activities | $ | 100.0 | $ | 107.0 | |||
| Purchases of property and equipment | (5.0 | ) | (7.0 | ) | |||
| Free cash flow | $ | 95.0 | $ | 100.0 |

Legal Disclaimer:
MENAFN provides the
information “as is” without warranty of any kind. We do not accept
any responsibility or liability for the accuracy, content, images,
videos, licenses, completeness, legality, or reliability of the information
contained in this article. If you have any complaints or copyright
issues related to this article, kindly contact the provider above.

Comments
No comment